Novo Nordisk A/S

NVONYSEHealthcare● Active

$42.96

$-0.79(-1.81%)

Market Cap$190.9B

P/E Ratio—

52W High$81.44

52W Low$35.12

Avg Volume16.4M

Open$44.05

Beta0.35

Overview

Novo Nordisk A/S (NVO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NVO · as of Feb 4, 2026

Latest filing snapshot

69,500

-5,500-7.33%vs prior year

Novo Nordisk A/S (NVO) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

69,500

Change (1Y)

-5,500

Growth % (1Y)

-7.33%

Revenue / Employee

$4.45M

Net Income / Employee

$1.47M

Market Cap

$190.9B

NVO Employee Count

2001 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-04	2025-12-31	69,500	-5,500	-7.33%
2025-02-05	2024-12-31	75,000	+15,000	+25.00%
2024-01-31	2023-12-31	60,000	+10,000	+20.00%
2023-02-01	2022-12-31	50,000	+5,000	+11.11%
2022-02-02	2021-12-31	45,000	+0	+0.00%
2021-02-03	2020-12-31	45,000	+1,700	+3.93%
2020-02-05	2019-12-31	43,300	+100	+0.23%
2019-02-04	2018-12-31	43,200	+1,100	+2.61%
2018-02-08	2017-12-31	42,100	-400	-0.94%
2017-02-09	2016-12-31	42,500	+1,500	+3.66%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Gilead Sciences, Inc.

17,600$160.4B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NVO peer comparison

About NVO employees

NVO Employees · Headcount

Novo Nordisk A/S (NVO) employee data is sourced from the annual SEC 20-F filing. As of 2025, Novo Nordisk A/S had 69,500 full-time employees globally. Full-time employees only. Global consolidated headcount.

Novo Nordisk A/S employs 69,500 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $4.45M, reflecting the company's operational efficiency.

Novo Nordisk A/S's workforce decreased by 5,500 (7.33%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Novo Nordisk A/S's revenue per employee of $4.45M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NVO Employees · 5 questions

As of the latest SEC 20-F filing (2025), Novo Nordisk A/S had 69,500 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Novo Nordisk A/S employee counthow many employees does Novo Nordisk A/S haveNVO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-04